The ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress

Health Security

Volumn 13, Issue 6, 2015, Pages 349-354

  Billington, John K ^a  

^a Infectious Diseases Society of America Emerging Infections Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; PUBLIC POLICY; RESEARCH; SUPPLY AND DISTRIBUTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FINANCING, GOVERNMENT; HUMANS; PUBLIC HEALTH; PUBLIC POLICY; RESEARCH; SECURITY MEASURES; UNITED STATES;

EID: 84987957980     PISSN: 23265094     EISSN: 23265108     Source Type: Journal    
DOI: 10.1089/hs.2015.0034     Document Type: Conference Paper

References (41)

1. Toner E, Adalja A, Gronvall GK, Cicero A, Inglesby TV. Antimicrobial resistance is a global health emergency. Health Secur 2015;13(3):153-155.
2. Allen HK, Trachsel J, Looft T, Casey TA. Finding alternatives to antibiotics. Ann N Y Acad Sci 2014;1323:91-100.
3. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. April 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed August 8, 2015.
4. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. April 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed August 8, 2015.
5. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Review on Antimicrobial Resistance, chaired by Jim O'Neill. December 2014. http://amr-review. org/sites/default/files/AMR%20Review%20Paper%20-%20 Tackling%20a%20crisis%20for%20the%20health%20and% 20wealth%20of%20nations_1.pdf. Accessed August 8, 2015.
6. Builder M. Antimicrobial Resistance as an Emerging Threat to National Security. Washington, DC: Atlantic Council; 2014. http://www.atlanticcouncil.org/images/files/Antimicrobial_Resistance_as_an_Emerging_Threat_to_National_Security.pdf. Accessed October 7, 2015.
7. Gostin LO, Fidler DP. Biosecurity under the rule of law. Case W Res J Int'l L 2007;38(3/4):437-478.
8. Perez F, VanDuin D. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med 2013;80(4):225-233.
9. Centers for Disease Control and Prevention. Vital signs: Carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013;62(9):165-170.
10. FalagasME, TansarliGS, KarageorgopoulosDE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014;20(7):1170-1175.
11. Fidler DP, Gostin LO. Biosecurity in the Global Age: Biological Weapons, Public Health, and the Rule of Law. Palo Alto, CA: Stanford University Press; 2008.
12. Koblentz GD. Biosecurity reconsidered: Calibrating biological threats and responses. Int Secur 2010;34(4):96-132.
13. Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, National Research Council. Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: National Academies Press; 2006.
14. Elbe S, Roemer-Mahler A, Long C. Medical countermeasures for national security: A new government role in the pharmaceuticalization of society. Soc Sci Med 2015;131:263-271.
15. Monaco L. Opening session at the White House Forum on Antibiotic Stewardship; June 2, 2015.
16. Rambhia KJ, Gronvall GK. Antibiotic resistance. Biosecur Bioterror 2009;7(4):371-377.
17. Boddie C, Watson M, Ackerman G, Gronvall GK. Assessing the bioweapons threat: Is there a foundation of agreement among experts about risk Science 2015;349(6250):792-793.
18. Peterson S. Epidemic disease and national security. Security Studies 2002;12(2):43-81.
19. U.S.C. x 247d-7e (2012) (enacted via Title IV of the Pandemic and All-Hazards Preparedness Act, Pub. L. No. 109-417).
20. US Department of Health and Human Services. BARDA Strategic Plan 2011-2016. 2011. http://www.phe.gov/about/barda/Documents/barda-strategic-plan.pdf. Accessed August 9, 2015.
21. Eichberg MJ. Public funding of clinical-stage antibiotic development in the United States and European Union. Health Secur 2015;13(3):156-165.
22. Larsen J. BARDA's Broad Spectrum Antimicrobial (BSA) Program. Presentation to the President's Council of Advisors on Science and Technology (PCAST); March 2015. https://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/Larsen, %20Joe.pdf. Accessed August 9, 2015.
23. US Department of Health and Human Services. 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan. 2014. http://www.phe.gov/Preparedness/mcm/phemce/Documents/2014-phemce-sip.pdf. Accessed August 12, 2015.
24. Larsen J. Presentation to U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR), convened by the Infectious Diseases Society of America (IDSA). August 2015. (Webinar archived and on file with author.)
25. Interview with Joe Larsen, Deputy Director, Division of CBRN Medical Countermeasures, BARDA, Arlington, VA; June 25, 2015.
26. Exec. Order No. 13676, 184 C.F.R. 56931 (2014).
27. The White House. National Action Plan for Combating Antibiotic-Resistant Bacteria. March 2015. https://www.white house.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf. Accessed August 9, 2015.
28. Innovative Medicines Initiative. New Drugs 4 Bad Bugs. http://www.imi.europa.eu/sites/default/files/uploads/documents/projects/ND4BB_overview.pdf. Accessed August 9, 2015.
29. HHS enters into strategic alliance to accelerate new antibiotic development [press release]. US Department of Health and Human Services. September 16, 2015. http://www.hhs.gov/news/press/2015pres/09/20150916a.html. Accessed October 7, 2015.
30. The White House. Fact Sheet: President's 2016 budget proposes historic investment to combat antibiotic-resistant bacteria to protect public health [press release]. January 27, 2015. https://www.whitehouse.gov/the-press-office/2015/01/27/factsheet-president-s-2016-budget-proposes-historic-investmentcombat- A. Accessed August 9, 2015.
31. Owens H, Arneil B. The human security paradigm shift: A new lens on Canadian foreign policy Report of the University of British Columbia symposium on human security. Canadian Foreign Policy Journal 1999;7(1):1-12.
32. Executive Office of the President, President's Council of Advisors on Science and Technology. Report to the President on Combating Antibiotic Resistance. September 2014. http://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast_carb_report_sept2014.pdf. Accessed August 10, 2015.
33. Medical and Public Health Preparedness and Response: Are We Ready for Future Threats Before the S. Health Ed. Labor & Pens. Comm., 114th Cong. (2015).
34. S. Rep. No. 114-74, at 14(2015).
35. H.R. Rep. No. 114-195, at 113 (2015).
36. Center for Responsive Politics. Alliance for Biosecurity. http://www.opensecrets.org/lobby/clientsum.phpid=D000046672& year=2014. Accessed August 9, 2015.
37. Alliance for Biosecurity. Our members. http://www.alliance forbiosecurity.org/#!contact/c1d94. Accessed August 9, 2015.
38. Antimicrobial Innovation Alliance. Key Issues: Incentives. http://www.antimicrobialalliance.com/incentives/. Accessed August 9, 2015.
39. Kesselheim AS, Outterson K. Improving antibiotic markets for long-term sustainability. Yale J Health Policy Law Ethics 2011;11(1):101-167.
40. Hoffman SJ, Outterson K. Introduction: What will it take to address the global threat of antibiotic resistance J Law Med Ethics 2015;43(Suppl 3):6-11.
41. Six Years After Anthrax: Are We Better Prepared to Respond to Bioterrorism: Hearing Before the S. Comm. on Homeland Sec. and Gov. Aff's., 110th Cong. (2007) (statement of Tara O'Toole, Director, Center for Biosecurity of UPMC).